Literature DB >> 17884061

Non-invasive detection of aortic and coronary atherosclerosis in homozygous familial hypercholesterolemia by 64 slice multi-detector row computed tomography angiography.

Raul D Santos1, Marcio H Miname, Lilton R C Martinez, Carlos E Rochitte, Ana P M Chacra, Edna R Nakandakare, David Chen, Ernst J Schaefer.   

Abstract

Homozygous familial hypercholesterolemia (HoFH) is a rare disorder characterized by the early onset of atherosclerosis, often at the ostia of coronary arteries. In this study we document for the first time that aortic and coronary atherosclerosis can be detected using 64 slice multiple detector row computed tomographic coronary angiography (CTCA). We studied five HoFH patients (three females, two males, mean age 19.8+/-2.9 years, age range 15-23 years, with a mean low density lipoprotein (LDL) cholesterol 618+/-211 mg/dL) using 64 slice CTCA. None of the patients showed evidence of ischemia with standard exercise testing. Calcified and mixed atherosclerotic plaques adjacent to or compromising the coronary artery ostia were found in all study subjects. Coronary plaques causing significant obstruction were found in one patient, who had previously undergone coronary artery bypass surgery and aortic valve replacement. Two other patients were noted to have non-obstructive calcified, mixed and non-calcified coronary artery plaques. Our data suggest that CTCA could be a useful non-invasive method for detection of early aortic and coronary atherosclerosis specifically affecting the coronary ostia in HoFH subjects.

Entities:  

Mesh:

Year:  2007        PMID: 17884061     DOI: 10.1016/j.atherosclerosis.2007.08.017

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

1.  Severe coronary and extracoronary atherosclerosis in autosomal recessive hypercholesterolemia detected by whole-body computed tomography angiography.

Authors:  Marcello Arca; Fabiana Quagliarini; Giovanni Pigna; Carlo Catalano; Alessandro Napoli
Journal:  Intern Emerg Med       Date:  2011-03-05       Impact factor: 3.397

2.  Fatal myocardial infarction at 4.5 years in a case of homozygous familial hypercholesterolaemia.

Authors:  Matthias Gautschi; Mladen Pavlovic; Jean-Marc Nuoffer
Journal:  JIMD Rep       Date:  2011-09-06

Review 3.  Inhibition of hepatic microsomal triglyceride transfer protein - a novel therapeutic option for treatment of homozygous familial hypercholesterolemia.

Authors:  Alpo Vuorio; Matti J Tikkanen; Petri T Kovanen
Journal:  Vasc Health Risk Manag       Date:  2014-05-06

Review 4.  Genetic Architecture of Familial Hypercholesterolaemia.

Authors:  Mahtab Sharifi; Marta Futema; Devaki Nair; Steve E Humphries
Journal:  Curr Cardiol Rep       Date:  2017-05       Impact factor: 2.931

5.  Homozygous Familial Hypercholesterolemia Associated with Symmetric Subcutaneous Lipomatosis.

Authors:  Noha Mohammed Dawoud; Ola Ahmed Bakry; Iman Seleit
Journal:  Indian J Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.494

6.  Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.

Authors:  Marina Cuchel; Eric Bruckert; Henry N Ginsberg; Frederick J Raal; Raul D Santos; Robert A Hegele; Jan Albert Kuivenhoven; Børge G Nordestgaard; Olivier S Descamps; Elisabeth Steinhagen-Thiessen; Anne Tybjærg-Hansen; Gerald F Watts; Maurizio Averna; Catherine Boileau; Jan Borén; Alberico L Catapano; Joep C Defesche; G Kees Hovingh; Steve E Humphries; Petri T Kovanen; Luis Masana; Päivi Pajukanta; Klaus G Parhofer; Kausik K Ray; Anton F H Stalenhoef; Erik Stroes; Marja-Riitta Taskinen; Albert Wiegman; Olov Wiklund; M John Chapman
Journal:  Eur Heart J       Date:  2014-07-22       Impact factor: 35.855

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.